B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co

4.9
(466)
Write Review
More
$ 13.99
Add to Cart
In stock
Description

Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]

Digital Diabetes Management Market Size, Trends & Forecast

Global Oncology

Velocity Global's 2022 Work In Progress Report: Businesses and talent benefit from

Organization, Facts & Figures

EANS-Tip Announcement: Hypo Vorarlberg Bank AG / Yearly financial

Stock Market News 2021-03-02

Topthema CES 2018

Where do lawsuits against B. Braun over cancer-causing chemical stand?

Leap by McKinsey Research Shows 50 Percent of Global Revenue Will

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Digital Diabetes Management Market Size, Trends & Forecast

B. Braun Melsungen AG

Continuous Renal Replacement Therapy Market Size, Share, Industry Forecast by 2032

ctso-20201231x10k001.jpg